Results Jade Biosciences Inc.
-
Management Change/Compensation (Form 8-K)
9/9
-
SEC Staff Letter (Form SEC STAFF LETTER)
8/21
-
SEC Staff Letter (Form SEC STAFF LETTER)
8/21
-
Amendment to New Listing Registration (Form 8-A12B/A)
8/13
-
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)
8/13
-
Statement of Changes in Beneficial Ownership (Form 4)
7/14
-
Initial Statement of Beneficial Ownership (Form 3)
7/14
-
Initial Registration Statement for Employee Benefit Plan (Form S-8)
6/30
-
Jade ERA 2025 Conference Call Presentation
6/9
-
European Renal Association 2025 Congress: JADE101 Presentation
6/6